Related Experiment Video
Updated: May 27, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace?
Louis P Perrault1, Alan J Moskowitz, Irving L Kron
1Department of Surgery, Montreal Heart Institute, University of Montréal, Montréal, Québec, Canada.
Insights
This study designs a clinical trial for ischemic mitral regurgitation, comparing mitral valve repair versus replacement. Evidence is needed to guide treatment choices for this high-mortality condition.
Area of Science:
- Cardiovascular Surgery
- Clinical Trials
- Heart Valve Disease
Background:
- Ischemic mitral regurgitation affects 2.8 million Americans, a complication of coronary artery disease with high mortality.
- Current guidelines recommend mitral valve repair or replacement, but evidence comparing interventions is lacking.
- Treatment decisions involve a trade-off between operative risk and long-term effectiveness, leading to varied surgical practices.
Purpose of the Study:
- To design a prospective randomized clinical trial evaluating mitral valve repair versus replacement for severe ischemic mitral regurgitation.
- To address challenges in defining primary endpoints, patient selection, and analytical strategies for this high-mortality disease.
Main Methods:
- Prospective randomized clinical trial design.
- Focus on evaluating safety and effectiveness of mitral valve repair and replacement.
- Part of the Cardiothoracic Surgical Trials Network.
Main Results:
- The article details the trial design, not preliminary results.
- Challenges in endpoint selection and patient characterization are discussed.
- Analytical considerations for high-mortality disease are addressed.
Conclusions:
- The trial aims to provide crucial data for therapeutic decision-making.
- Information on functional status, survival, neurocognition, quality of life, and cardiac physiology will be gathered.
- Findings will inform optimal surgical strategies for ischemic mitral regurgitation.
Background:
Ischemic mitral regurgitation, a complication of myocardial infarction and coronary artery disease more generally, is associated with a high mortality rate and is estimated to affect 2.8 million Americans. With 1-year mortality rates as high as 40%, recent practice guidelines of professional societies recommend repair or replacement, but there remains a lack of conclusive evidence supporting either intervention. The choice between therapeutic options is characterized by the trade-off between reduced operative morbidity and mortality with repair versus a better long-term correction of mitral insufficiency with replacement. The long-term benefits of repair versus replacement remain unknown, which has led to significant variation in surgical practice.
Methods And Results:
This article describes the design of a prospective randomized clinical trial to evaluate the safety and effectiveness of mitral valve repair and replacement in patients with severe ischemic mitral regurgitation. This trial is being conducted as part of the Cardiothoracic Surgical Trials Network. This article addresses challenges in selecting a feasible primary end point, characterizing the target population (including the degree of mitral regurgitation) and analytical challenges in this high mortality disease.
Conclusions:
The article concludes by discussing the importance of information on functional status, survival, neurocognition, quality of life, and cardiac physiology in therapeutic decision making.
Related Concept Videos
Mitral Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Regurgitation IV: Nursing Management
Aortic Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction

